Clinical Trials Logo

Filter by:
NCT ID: NCT03706963 Terminated - Abdominal Surgery Clinical Trials

Remote Telemonitoring to Improve Prehabilitation and Surgical Outcomes of Patients Undergoing Elective Abdominal Surgery

Start date: January 15, 2019
Phase: N/A
Study type: Interventional

There is data confirming that simple tests of physical capability, such as the timed "get-up-and-go" test and the 6-minute walk test, correlate with surgical outcomes. It is reasonable to assume that preoperative telemonitoring, which allows for the tracking of more variables over a wider range of activities, could provide a significantly more accurate picture of a patient's physical fitness than a short one-time test performed in the clinic setting. Almost half of the patients who are readmitted at Washington University are readmitted for less than 4 days. The readmitted patients usually present with sepsis, are treated with antibiotics and percutaneous drainage, and are discharged home relatively quickly. Earlier identification of these patients, prior to the development of sepsis, would reduce the risks to the patient and allow for outpatient management.

NCT ID: NCT03706521 Terminated - Knee Osteoarthritis Clinical Trials

A Study Utilizing Imaging Techniques and Evaluating the Safety and Efficacy of SM04690 for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthritis

Start date: March 11, 2019
Phase: Phase 2
Study type: Interventional

This phase 2 study is a single center, open-label study of SM04690 injected intraarticularly (IA) into the target knee (most painful) joint of moderately to severely symptomatic osteoarthritis (OA) subjects at a single dose of 0.07 mg SM04690 per 2 mL injection. This study will utilize magnetic resonance imaging (MRI) (including T1rho and T2 mapping pulse sequence MRI, three-dimensional spoiled gradient recalled [3D-SPGR] pulse sequence MRI, and whole organ MRI scoring [WORMS]), radiographic imaging, Western Ontario and McMaster Universities Arthritis Index (WOMAC) and patient reported outcomes (PROs) for data collection to assess efficacy outcome measures.

NCT ID: NCT03706430 Terminated - Surgery Clinical Trials

Validation of RPVi as a Parameter to Predict Fluid Responsiveness

Start date: September 24, 2018
Phase:
Study type: Interventional

This is a prospective, nonrandomized, sequential data collection study to evaluate the ability of RPVi to predict fluid responsiveness in comparison with other dynamic parameters including stroke volume variation (SVV) and/or pulse pressure variation (PPV).

NCT ID: NCT03706053 Terminated - Septic Shock Clinical Trials

Midodrine Use in Septic Shock

Start date: November 5, 2018
Phase: Phase 3
Study type: Interventional

The investigators aim to perform a randomized, double-blind, placebo-controlled trial to investigate the efficacy of midodrine in decreasing time to IV vasopressor liberation in patients with septic shock.

NCT ID: NCT03705962 Terminated - Fractures, Open Clinical Trials

Locally Applied Antibiotics for Infection Prophylaxis in Treatment of Open Fractures

Start date: July 2015
Phase: Phase 3
Study type: Interventional

The primary objective of this study is to investigate the effectiveness of local antibiotic versus placebo in the prevention of infections in open fractures. The study will assess whether local treatment of open fractures with the antibiotic tobramycin (in addition to standard systemic antibiotics) will decrease the risk and rate of infection, and rate of re-operation. This will be studied using a randomized controlled clinical trial design in adult population of age 18-70 years who present with open fractures. About 133 subjects will be recruited in this study at UVA.

NCT ID: NCT03705637 Terminated - Postoperative Pain Clinical Trials

Liposomal Bupivicaine for Skin Graft Donor Sites in Burn Patients

Start date: June 1, 2019
Phase: Early Phase 1
Study type: Interventional

Burn injuries are painful to patients and the sources of pain result from many areas including: the injury itself, wound care, and surgery. Inpatients that require surgical skin grafting is often required and the donor site of a skin graft is quite painful for patients. The investigators try to minimize that pain with local anesthetic as well as a combination of pain medications, the donor site pain lasts for days and is what patients often report as being the most painful part of their burn care. There has been the development of a new form of local anesthesia that can last up to 72 hours when injected into tissue. Based on encouraging results in the literature in areas outside of burns, this study aims to evaluate whether administration of this medication at the time of surgery can help improve pain for burn patients in the postoperative period.

NCT ID: NCT03705351 Terminated - Glioblastoma Clinical Trials

Tumor Treating Fields With Chemoradiation in Newly Diagnosed GBM

Start date: December 2, 2019
Phase: Phase 1
Study type: Interventional

The study is an open-label pilot study in newly diagnosed glioblastoma patients following surgery. Eligible patients will receive treatment with tumor treating fields therapy using the Optune device starting less than 2 weeks prior to start of chemoradiation. Patients will receive radiation and temozolomide at a routine treatment dose and schedule.

NCT ID: NCT03705273 Terminated - Asthma Clinical Trials

Comparison of Dexamethasone Oral Preparations to Assess Taste and Acceptance in Children With Asthma and Croup

Start date: October 23, 2018
Phase: Phase 4
Study type: Interventional

Study of the palatability and acceptability of dexamethasone oral tablets crushed and placed in apple sauce or pudding in comparison with the IV solution mixed with sugar syrup and given orally. It is hypothesized that dexamethasone tablets crushed and administered in apple sauce or pudding will be more palatable and acceptable for pediatric patients receiving dexamethasone for an acute asthma exacerbation or croup.

NCT ID: NCT03705169 Terminated - HIV-1-infection Clinical Trials

Pharmacokinetics and Safety of SAR441236

Start date: May 20, 2019
Phase: Phase 1
Study type: Interventional

The purpose of this study was to evaluate the safety, tolerability, pharmacokinetics, and antiviral activity of SAR441236, a tri-specific broadly neutralizing antibody against the human immunodeficiency virus (HIV).

NCT ID: NCT03705013 Terminated - Colorectal Cancer Clinical Trials

Observational Study of Sub-populations From Cologuard Post-Approval Study (2014-01)

Start date: October 30, 2018
Phase:
Study type: Observational

The primary endpoint is to obtain longitudinal information on four sub-populations from the Cologuard Post-Approval Study.